2-168958145-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003742.4(ABCB11):​c.2179-17C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.526 in 1,605,162 control chromosomes in the GnomAD database, including 226,548 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.47 ( 17710 hom., cov: 31)
Exomes 𝑓: 0.53 ( 208838 hom. )

Consequence

ABCB11
NM_003742.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.0820

Publications

21 publications found
Variant links:
Genes affected
ABCB11 (HGNC:42): (ATP binding cassette subfamily B member 11) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is the major canalicular bile salt export pump in man. Mutations in this gene cause a form of progressive familial intrahepatic cholestases which are a group of inherited disorders with severe cholestatic liver disease from early infancy. [provided by RefSeq, Jul 2008]
ABCB11 Gene-Disease associations (from GenCC):
  • progressive familial intrahepatic cholestasis type 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • benign recurrent intrahepatic cholestasis type 2
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 2-168958145-G-T is Benign according to our data. Variant chr2-168958145-G-T is described in ClinVar as Benign. ClinVar VariationId is 259147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.632 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABCB11NM_003742.4 linkc.2179-17C>A intron_variant Intron 18 of 27 ENST00000650372.1 NP_003733.2 O95342

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABCB11ENST00000650372.1 linkc.2179-17C>A intron_variant Intron 18 of 27 NM_003742.4 ENSP00000497931.1 O95342
ABCB11ENST00000649448.1 linkc.496-17C>A intron_variant Intron 4 of 14 ENSP00000497165.1 A0A3B3IS78
ABCB11ENST00000439188.1 linkn.*649-17C>A intron_variant Intron 5 of 14 2 ENSP00000416058.1 H7C486

Frequencies

GnomAD3 genomes
AF:
0.466
AC:
70467
AN:
151290
Hom.:
17717
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.272
Gnomad AMI
AF:
0.730
Gnomad AMR
AF:
0.517
Gnomad ASJ
AF:
0.592
Gnomad EAS
AF:
0.640
Gnomad SAS
AF:
0.652
Gnomad FIN
AF:
0.537
Gnomad MID
AF:
0.541
Gnomad NFE
AF:
0.524
Gnomad OTH
AF:
0.495
GnomAD2 exomes
AF:
0.547
AC:
133904
AN:
244912
AF XY:
0.553
show subpopulations
Gnomad AFR exome
AF:
0.265
Gnomad AMR exome
AF:
0.597
Gnomad ASJ exome
AF:
0.605
Gnomad EAS exome
AF:
0.636
Gnomad FIN exome
AF:
0.527
Gnomad NFE exome
AF:
0.526
Gnomad OTH exome
AF:
0.535
GnomAD4 exome
AF:
0.532
AC:
774065
AN:
1453754
Hom.:
208838
Cov.:
32
AF XY:
0.537
AC XY:
388425
AN XY:
723142
show subpopulations
African (AFR)
AF:
0.264
AC:
8755
AN:
33220
American (AMR)
AF:
0.583
AC:
25969
AN:
44512
Ashkenazi Jewish (ASJ)
AF:
0.605
AC:
15678
AN:
25932
East Asian (EAS)
AF:
0.612
AC:
24210
AN:
39576
South Asian (SAS)
AF:
0.653
AC:
56085
AN:
85944
European-Finnish (FIN)
AF:
0.522
AC:
27480
AN:
52636
Middle Eastern (MID)
AF:
0.565
AC:
3145
AN:
5562
European-Non Finnish (NFE)
AF:
0.525
AC:
580707
AN:
1106370
Other (OTH)
AF:
0.534
AC:
32036
AN:
60002
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
16053
32106
48160
64213
80266
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16734
33468
50202
66936
83670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.465
AC:
70479
AN:
151408
Hom.:
17710
Cov.:
31
AF XY:
0.473
AC XY:
34984
AN XY:
73942
show subpopulations
African (AFR)
AF:
0.272
AC:
11252
AN:
41388
American (AMR)
AF:
0.518
AC:
7877
AN:
15198
Ashkenazi Jewish (ASJ)
AF:
0.592
AC:
2045
AN:
3456
East Asian (EAS)
AF:
0.640
AC:
3257
AN:
5088
South Asian (SAS)
AF:
0.651
AC:
3136
AN:
4820
European-Finnish (FIN)
AF:
0.537
AC:
5659
AN:
10532
Middle Eastern (MID)
AF:
0.531
AC:
156
AN:
294
European-Non Finnish (NFE)
AF:
0.524
AC:
35408
AN:
67626
Other (OTH)
AF:
0.489
AC:
1026
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1807
3614
5422
7229
9036
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
646
1292
1938
2584
3230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.510
Hom.:
36046
Bravo
AF:
0.453
Asia WGS
AF:
0.605
AC:
2102
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 02, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Benign recurrent intrahepatic cholestasis type 2 Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Progressive familial intrahepatic cholestasis type 2 Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
3.4
DANN
Benign
0.58
PhyloP100
0.082
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs853772; hg19: chr2-169814655; API